Eyepoint Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $566k | 40k | 14.24 |
| 2025-06-30 | $374k | 40k | 9.41 |
| 2025-03-31 | $215k | 40k | 5.42 |
| 2024-12-31 | $302k | 41k | 7.45 |
| 2024-09-30 | $234k | 29k | 7.99 |
| 2024-06-30 | $255k | 29k | 8.70 |
| 2023-12-31 | $323k | 14k | 23.11 |
| 2023-09-30 | $112k | 14k | 7.99 |
| 2023-06-30 | $122k | 14k | 8.70 |
| 2022-09-30 | $102k | 13k | 7.91 |
| 2022-06-30 | $101k | 13k | 7.87 |
| 2022-03-31 | $156k | 13k | 12.15 |
| 2021-12-31 | $101k | 8.3k | 12.24 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors